Download PDF
J Knee Surg 2011; 24(1): 025-032
DOI: 10.1055/s-0031-1275404
ORIGINAL ARTICLE

© Thieme Medical Publishers

Who Needs Autologous Blood Donation in Joint Replacement?

Javad Parvizi1 , Sonia Chaudhry1 , Mohammad R. Rasouli1 , Luis Pulido1 , Ashish Joshi1 , Jay H. Herman1 , Richard H. Rothman1
  • 1Department of Orthopaedics, Rothman Institute at Thomas Jefferson University, Philadelphia, Pennsylvania
Further Information

Publication History

Publication Date:
23 March 2011 (online)

    Permissions and Reprints

ABSTRACT

Conflicting results are available about the efficacy of routine preoperative autologous donation (PAD) in reducing allogenic blood transfusion during total joint arthroplasty (TJA). This study aimed to determine if PAD is effective in reducing the need for allogenic transfusion after TJA. For this retrospective study, data on 409 patients who received total knee arthroplasty (TKA) and 513 who underwent total hip arthroplasty (THA) from January to June 2005 were evaluated. It is our institutional policy to offer preoperative donation to all patients. Based on patient decision, preoperative hemoglobin, and other factors, PAD may or may not take place. Five hundred forty-six (61%) patients donated on average 1.3 units (range, 1 to 2) of blood. Autologous and allogenic transfusions were respectively performed in 91% (514 patients) and 24% of our cohort. The rate of allogenic transfusion after TKA was lower in the PAD group at 21% versus 27% among the nondonors, although it was not statistically significant (p = 0.10). The allogenic transfusion rate after THA was significantly lower among autologous donors (16% versus 34%, p = 0.003). Advanced age, lower body mass index, simultaneous bilateral arthroplasty, and lower preoperative hemoglobin were independently associated with increased allogenic blood transfusion. PAD seems to be effective in reducing allogenic transfusions after THA but not TKA.

KEYWORDS

Preoperative autologous donation - allogenic transfusion - total joint arthroplasty - risk factors

REFERENCES

  • 1 Bierbaum B E, Callaghan J J, Galante J O, Rubash H E, Tooms R E, Welch R B. An analysis of blood management in patients having a total hip or knee arthroplasty.  J Bone Joint Surg Am. 1999;  81 2-10
    CrossrefPubMedGoogle Scholar
  • 2 Parvizi J, Mui A, Purtill J J, Sharkey P F, Hozack W J, Rothman R H. Total joint arthroplasty: When do fatal or near-fatal complications occur?.  J Bone Joint Surg Am. 2007;  89 27-32
    CrossrefPubMedGoogle Scholar
  • 3 Spahn D R, Casutt M. Eliminating blood transfusions: new aspects and perspectives.  Anesthesiology. 2000;  93 242-255
    CrossrefPubMedGoogle Scholar
  • 4 Sculco T P, Baldini A, Keating E M. Blood management in total joint arthroplasty.  Instr Course Lect. 2005;  54 51-66
    PubMedGoogle Scholar
  • 5 Hays M B, Mayfield J F. Total blood loss in major joint arthroplasty. A comparison of cemented and noncemented hip and knee operations.  J Arthroplasty. 1988;  3 (Suppl) S47-S49
    CrossrefPubMedGoogle Scholar
  • 6 Grosvenor D, Goyal V, Goodman S. Efficacy of postoperative blood salvage following total hip arthroplasty in patients with and without deposited autologous units.  J Bone Joint Surg Am. 2000;  82 951-954
    PubMedGoogle Scholar
  • 7 Hébert P C, Wells G, Blajchman M A et al.. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.  N Engl J Med. 1999;  340 409-417
    CrossrefPubMedGoogle Scholar
  • 8 Murphy P, Heal J M, Blumberg N. Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions.  Transfusion. 1991;  31 212-217
    CrossrefPubMedGoogle Scholar
  • 9 Weber E W, Slappendel R, Prins M H, van der Schaaf D B, Durieux M E, Strümper D. Perioperative blood transfusions and delayed wound healing after hip replacement surgery: Effects on duration of hospitalization.  Anesth Analg. 2005;  100 1416-1421
    CrossrefPubMedGoogle Scholar
  • 10 Feagan B G, Wong C J, Johnston W C et al.. Transfusion practices for elective orthopedic surgery.  CMAJ. 2002;  166 310-314
    PubMedGoogle Scholar
  • 11 Salido J A, Marín L A, Gómez L A, Zorrilla P, Martínez C. Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: Analysis of predictive factors.  J Bone Joint Surg Am. 2002;  84 216-220
    CrossrefPubMedGoogle Scholar
  • 12 Feagan B G, Wong C J, Kirkley A et al.. Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial.  Ann Intern Med. 2000;  133 845-854
    PubMedGoogle Scholar
  • 13 Sinclair K C, Clarke H D, Noble B N. Blood management in total knee arthroplasty: A comparison of techniques.  Orthopedics. 2009;  32 19
    CrossrefPubMedGoogle Scholar
  • 14 Gonzalez-Porras J R, Colado E, Conde M P, Lopez T, Nieto M J, Corral M. An individualized pre-operative blood saving protocol can increase pre-operative haemoglobin levels and reduce the need for transfusion in elective total hip or knee arthroplasty.  Transfus Med. 2009;  19 35-42
    CrossrefPubMedGoogle Scholar
  • 15 Han C D, Shin D E. Postoperative blood salvage and reinfusion after total joint arthroplasty.  J Arthroplasty. 1997;  12 511-516
    CrossrefPubMedGoogle Scholar
  • 16 Kinzel V, Shakespeare D, Derbyshire D. The effect of aprotinin on blood loss in bilateral total knee arthroplasty.  Knee. 2005;  12 107-111
    CrossrefPubMedGoogle Scholar
  • 17 Levy O, Martinowitz U, Oran A, Tauber C, Horoszowski H. The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study.  J Bone Joint Surg Am. 1999;  81 1580-1588
    PubMedGoogle Scholar
  • 18 Orpen N M, Little C, Walker G, Crawfurd E J. Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: A prospective randomised controlled trial of 29 patients.  Knee. 2006;  13 106-110
    CrossrefPubMedGoogle Scholar
  • 19 Colwell Jr C W, Chelly J E, Murkin J M et al.. Randomized study of aprotinin effect on transfusions and blood loss in primary THA.  Clin Orthop Relat Res. 2007;  465 189-195
    PubMedGoogle Scholar
  • 20 Hatzidakis A M, Mendlick R M, McKillip T, Reddy R L, Garvin K L. Preoperative autologous donation for total joint arthroplasty. An analysis of risk factors for allogenic transfusion.  J Bone Joint Surg Am. 2000;  82 89-100
    PubMedGoogle Scholar
  • 21 Billote D B, Glisson S N, Green D, Wixson R L. A prospective, randomized study of preoperative autologous donation for hip replacement surgery.  J Bone Joint Surg Am. 2002;  84 1299-1304
    PubMedGoogle Scholar
  • 22 Henry D A, Carless P A, Moxey A J et al.. Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion.  Cochrane Database Syst Rev. 2002;  (2) CD003602
    PubMedGoogle Scholar
  • 23 Etchason J, Petz L, Keeler E et al.. The cost effectiveness of preoperative autologous blood donations.  N Engl J Med. 1995;  332 719-724
    CrossrefPubMedGoogle Scholar
  • 24 American Association of Blood Banks. Standards for Blood Banks and Transfusion 241 Services. Bethesda, MD: American Association of Blood Banks; 2002
    Google Scholar
  • 25 Rosencher N, Kerkkamp H E, Macheras G OSTHEO Investigation et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe.  Transfusion. 2003;  43 459-469
    CrossrefPubMedGoogle Scholar
  • 26 Zimlich R H, Fulbright B M, Friedman R J. Current status of anticoagulation therapy after total hip and total knee arthroplasty.  J Am Acad Orthop Surg. 1996;  4 54-62
    PubMedGoogle Scholar
  • 27 Geerts W H, Bergqvist D, Pineo G F American College of Chest Physicians et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).  Chest. 2008;  133 (6, Suppl) 381S-453S
    CrossrefPubMedGoogle Scholar
  • 28 Murphy M F, Wallington T B, Kelsey P British Committee for Standards in Haematology, Blood Transfusion Task Force et al. Guidelines for the clinical use of red cell transfusions.  Br J Haematol. 2001;  113 24-31
    CrossrefPubMedGoogle Scholar
  • 29 Iturbe T, Cornudella R, de Miguel R et al.. Hypercoagulability state in hip and knee surgery: Influence of ABO antigenic system and allogenic transfusion.  Transfus Sci. 1999;  20 17-20
    CrossrefPubMedGoogle Scholar
  • 30 Blumberg N, Heal J M. Immunomodulation by blood transfusion: An evolving scientific and clinical challenge.  Am J Med. 1996;  101 299-308
    CrossrefPubMedGoogle Scholar
  • 31 Transfusion Alert: Use of autologous blood. National Heart, Lung, and Blood Institute Expert Panel on the Use of Autologous Blood.  Transfusion. 1995;  35 703-711
    CrossrefPubMedGoogle Scholar
  • 32 Woolson S T, Watt J M. Use of autologous blood in total hip replacement. A comprehensive program.  J Bone Joint Surg Am. 1991;  73 76-80
    PubMedGoogle Scholar
  • 33 Thomson J D, Callaghan J J, Savory C G, Stanton R P, Pierce R N. Prior deposition of autologous blood in elective orthopaedic surgery.  J Bone Joint Surg Am. 1987;  69 320-324
    PubMedGoogle Scholar
  • 34 Lemos M J, Healy W L. Blood transfusion in orthopaedic operations.  J Bone Joint Surg Am. 1996;  78 1260-1270
    PubMedGoogle Scholar
  • 35 Smith T O, Hing C B. Is a tourniquet beneficial in total knee replacement surgery? A meta-analysis and systematic review.  Knee. 2010;  17 141-147
    CrossrefPubMedGoogle Scholar
  • 36 Lee S J, Liljas B, Churchill W H et al.. Perceptions and preferences of autologous blood donors.  Transfusion. 1998;  38 757-763
    CrossrefPubMedGoogle Scholar
  • 37 Anders M J, Lifeso R M, Landis M, Mikulsky J, Meinking C, McCracken K S. Effect of preoperative donation of autologous blood on deep-vein thrombosis following total joint arthroplasty of the hip or knee.  J Bone Joint Surg Am. 1996;  78 574-580
    PubMedGoogle Scholar
  • 38 Popovsky M A, Whitaker B, Arnold N L. Severe outcomes of allogeneic and autologous blood donation: Frequency and characterization.  Transfusion. 1995;  35 734-737
    CrossrefPubMedGoogle Scholar
  • 39 Karkouti K, McCluskey S A, Evans L, Mahomed N, Ghannam M, Davey R. Erythropoietin is an effective clinical modality for reducing RBC transfusion in joint surgery.  Can J Anaesth. 2005;  52 362-368
    CrossrefPubMedGoogle Scholar
  • 40 Green W S, Toy P, Bozic K J. Cost minimization analysis of preoperative erythropoietin vs autologous and allogeneic blood donation in total joint arthroplasty.  J Arthroplasty. 2010;  25 93-96
    CrossrefPubMedGoogle Scholar
  • 41 Pola E, Papaleo P, Santoliquido A, Gasparini G, Aulisa L, De Santis E. Clinical factors associated with an increased risk of perioperative blood transfusion in nonanemic patients undergoing total hip arthroplasty.  J Bone Joint Surg Am. 2004;  86 57-61
    CrossrefPubMedGoogle Scholar
  • 42 Bhan S, Pankaj A, Malhotra R. One- or two-stage bilateral total hip arthroplasty: A prospective, randomised, controlled study in an Asian population.  J Bone Joint Surg Br. 2006;  88 298-303
    CrossrefPubMedGoogle Scholar
  • 43 Tsiridis E, Pavlou G, Charity J, Tsiridis E, Gie G, West R. The safety and efficacy of bilateral simultaneous total hip replacement: An analysis of 2063 cases.  J Bone Joint Surg Br. 2008;  90 1005-1012
    CrossrefPubMedGoogle Scholar
  • 44 Walsh M, Preston C, Bong M, Patel V, Di Cesare P E. Relative risk factors for requirement of blood transfusion after total hip arthroplasty.  J Arthroplasty. 2007;  22 1162-1167
    CrossrefPubMedGoogle Scholar
  • 45 Moran M, Walmsley P, Gray A, Brenkel I J. Does body mass index affect the early outcome of primary total hip arthroplasty?.  J Arthroplasty. 2005;  20 866-869
    CrossrefPubMedGoogle Scholar
  • 46 Bowditch M G, Villar R N. Do obese patients bleed more? A prospective study of blood loss at total hip replacement.  Ann R Coll Surg Engl. 1999;  81 198-200
    PubMedGoogle Scholar

Javad ParviziM.D. 

Department of Orthopaedics, Rothman Institute at Thomas Jefferson University, 925 Chestnut Street

5th Floor, Philadelphia, PA 19107

Email: parvj@aol.com

      >